Expression of p21WAF1/Cip1 through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase–PKCε signaling pathway
Authors:
- Eun-Jung ChoECEun-Jung Cho
- Hoi Young LeeHLHoi Young Lee
- Hyang-Woo LeeHLHyang-Woo Lee
- 4 September 2003
- journal article
- Published by Springer Nature in Oncogene
- Vol. 22 (38) , 6023-6031
Abstract
We previously reported that the activation of p21WAF1/Cip1 transcription by histone deacetylase inhibitor apicidin was mediated through Sp1 sites and pointed to the possible participation of protein kinase C (PKC). In this study, we investigated the role and identity of the specific isoforms of PKC involved and identified phosphatidylinositol 3-kinase (PI 3-kinase) as an upstream effector in HeLa cells. Using an isoform-specific pharmacological inhibitor of PKC, a PKC dominant-negative mutant, and antisense oligonucleotide to inhibit PKC specifically, we found that among PKC isoforms, PKC was required for the p21WAF1/Cip1 expression by apicidin. In addition to PKC, PI 3-kinase appeared to participate in the activation of p21WAF1/Cip1 promoter by apicidin, since inactivation of PI 3-kinase either by transient expression of dominant-negative mutant of PI 3-kinase or its specific inhibitors, LY294002 and wortmannin, attenuated the activation of p21WAF1/Cip1 promoter and p21WAF1/Cip1 protein expression by apicidin. Furthermore, membrane translocation of PKC in response to apicidin was blocked by the PI 3-kinase inhibitor, indicating the role of PI 3-kinase as an upstream molecule of PKC in the p21WAF1/Cip1 promoter activation by apicidin. However, the p21WAF1/Cip1 expression by apicidin appeared to be independent of the histone hyperacetylation, since apicidin-induced histone hyperacetylation of p21WAF1/Cip1 promoter region was not affected by inhibition of PI 3-kinase and PKC, suggesting that the chromatin remodeling through the histone hyperacetylation alone might not be sufficient for the expression of p21WAF1/Cip1 by apicidin. Taken together, these results suggest that the PI 3-kinase–PKC signaling pathway plays a pivotal role in the expression of the p21WAF1/Cip1 by apicidin.Keywords
This publication has 55 references indexed in Scilit:
- Regulation of the activity of Sp1-related transcription factorsMolecular and Cellular Endocrinology, 2002
- Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complexBiochemical and Biophysical Research Communications, 2002
- Regulation of novel protein kinase C ε by phosphorylationBiochemical Journal, 2002
- Transcription factor Sp3 is regulated by acetylationNucleic Acids Research, 2001
- Involvement of p21 Waf1/Cip1 in Protein Kinase C Alpha-Induced Cell Cycle ProgressionMolecular and Cellular Biology, 2000
- Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase BCurrent Biology, 1998
- Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21 WAF1/CIP1 Mediated by STAT1Science, 1996
- Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 PromoterJournal of Biological Chemistry, 1995
- Mammalian G1 cyclinsCurrent Opinion in Cell Biology, 1994
- Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.Journal of Clinical Investigation, 1991